Rafferty Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-77,078
| Closed | -$8.92M | – | 1111 |
|
|
2023
Q3 | $8.92M | Sell |
77,078
-6,707
| -8% | -$776K | 0.05% | 253 |
|
|
2023
Q2 | $8.62M | Buy |
83,785
+21,919
| +35% | +$2.25M | 0.05% | 240 |
|
|
2023
Q1 | $6.75M | Sell |
61,866
-21,019
| -25% | -$2.29M | 0.05% | 303 |
|
|
2022
Q4 | $9.43M | Sell |
82,885
-22,000
| -21% | -$2.5M | 0.08% | 190 |
|
|
2022
Q3 | $6.49M | Buy |
104,885
+60,154
| +134% | +$3.72M | 0.07% | 252 |
|
|
2022
Q2 | $3.57M | Sell |
44,731
-8,333
| -16% | -$665K | 0.03% | 353 |
|
|
2022
Q1 | $5.58M | Buy |
53,064
+650
| +1% | +$68.4K | 0.03% | 361 |
|
|
2021
Q4 | $5.65M | Buy |
52,414
+23,496
| +81% | +$2.53M | 0.03% | 339 |
|
|
2021
Q3 | $3.17M | Buy |
28,918
+956
| +3% | +$105K | 0.02% | 447 |
|
|
2021
Q2 | $2.62M | Buy |
27,962
+23,794
| +571% | +$2.23M | 0.02% | 570 |
|
|
2021
Q1 | $384K | Sell |
4,168
-2,231
| -35% | -$206K | ﹤0.01% | 1025 |
|
|
2020
Q4 | $468K | Buy |
6,399
+1,029
| +19% | +$75.3K | ﹤0.01% | 699 |
|
|
2020
Q3 | $417K | Sell |
5,370
-1,117
| -17% | -$86.7K | 0.01% | 737 |
|
|
2020
Q2 | $361K | Buy |
+6,487
| New | +$361K | 0.01% | 788 |
|
|
2020
Q1 | – | Sell |
-12,104
| Closed | -$438K | – | 896 |
|
|
2019
Q4 | $438K | Sell |
12,104
-7,072
| -37% | -$256K | 0.01% | 710 |
|
|
2019
Q3 | $522K | Buy |
19,176
+8,393
| +78% | +$228K | 0.01% | 657 |
|
|
2019
Q2 | $259K | Buy |
+10,783
| New | +$259K | ﹤0.01% | 760 |
|